Aptamer Sciences Inc (KOSDAQ:291650)
South Korea · Delayed Price · Currency is KRW 1,383.00
-15.00 (-1.07%)
At close: Mar 13, 2026
Aptamer Sciences Market Cap
Aptamer Sciences has a market cap or net worth of 55.68 billion as of March 13, 2026. Its market cap has increased by 101.85% in one year.
Market Cap
55.68B
Enterprise Value
46.20B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
1,383.00
Market Cap Chart
Since September 16, 2020, Aptamer Sciences's market cap has decreased from 234.93B to 55.68B, a decrease of -76.30%. That is a compound annual growth rate of -23.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 55.68B | 82.45% |
| Dec 30, 2025 | 30.51B | -4.74% |
| Dec 30, 2024 | 32.03B | -47.67% |
| Dec 28, 2023 | 61.21B | -17.60% |
| Dec 29, 2022 | 74.29B | -48.53% |
| Dec 30, 2021 | 144.35B | -36.85% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Parataxis Korea | 80.62B |
| Naturalendo Tech | 79.88B |
| Shaperon | 79.58B |
| Ark Solutions | 68.91B |
| PanGen Biotech | 66.86B |
| HLB Pep | 65.80B |
| EyeGene | 65.54B |
| SunBio,Inc. | 61.21B |